The artificial intelligence ai in wound care market has seen considerable growth due to a variety of factors.
• The market size for artificial intelligence (AI) in wound care has experienced exponential growth in recent times. The anticipated growth will see it increase from $0.79 billion in 2024 to $0.97 billion in 2025, with a compound annual growth rate (CAGR) of 23.1%.
Factors that have contributed to this growth in the historical period include the high costs associated with healthcare, more widespread use of digital health solutions, better methods of data aggregation and analysis, and improved clinical decision-making support.
The artificial intelligence ai in wound care market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipated to surge significantly in the coming years, the market size of artificial intelligence (AI) in wound care is projected to reach $2.21 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 22.8%.
This growth in the projected period can be credited to factors such as the increasing cases of chronic wounds, the escalated expenditure on healthcare, the growing recognition of AI benefits in the medical field, early adoption of AI for wound analysis, and the initial support from the government for digital health projects. Key trends for the forecast period encompass a rise in utilization of AI-enabled diagnostic instruments, customized wound care solutions, investments in AI-fueled healthcare technologies, and a heightened interest in AI for the treatment of chronic wounds.
The escalation of diabetes cases is anticipated to fuel the advancement of the artificial intelligence (AI) in the wound care market in the future. Characterized by high blood sugar levels, diabetes is a persistent condition that can result in complications like heart disease, kidney failure, neuropathy, and vision loss. The growth in diabetes cases can be largely attributed to the increase in obesity rates, which subsequently raises the risk of type 2 diabetes, and the aging population, as the chance of acquiring diabetes amplifies with age. AI assistance in wound care enhances diabetes management through precise wound evaluations and tailored treatment plans, thereby boosting the efficacy of treating diabetic ulcers. For example, the Centers for Disease Control and Prevention, a U.S. government organization, reported in May 2024 that 38.4 million or 11.6% of the U.S. population had diabetes. The prevalence was notably higher at 29.2% among adults aged 65 and above. Consequently, the burgeoning cases of diabetes are stimulating the expansion of the artificial intelligence (AI) in the wound care market.
The artificial intelligence (AI) in wound care market covered in this report is segmented –
1) By Type Of Wound: Acute Wounds, Chronic Wounds
2) By Technology: Deep Learning, Machine Learning, Other Technologies
3) By End User: Clinical Trials And Research Centers, Home Health Agencies, Hospitals, Nursing Facilities, Other End Users
Subsegments:
1) By Acute Wounds: Surgical Wounds, Traumatic Wounds, Burns
2) By Chronic Wounds: Diabetic Foot Ulcers, Pressure Ulcers (Bedsores), Venous Leg Ulcers, Arterial Ulcers
Prominent enterprises in the AI in wound care market are prioritizing the creation of advanced technological solutions such as state-of-the-art digital wound care management applications. These innovative tools promise to upgrade wound assessment processes and improve treatment results. Utilizing technology-based applications, the wound healing process can be evaluated, monitored, and managed, offering tailored treatment options and the facility of distant patient supervision. For example, in June 2022, NATROX Wound Care, an expert wound care company established in the UK, introduced NATROX IQ. This is a sophisticated digital platform energized by AI techniques, intended to transform the approach of clinical teams towards wound care management. This unique cloud-supported application augments standardized documentation and facilitates live access to data, thus enabling healthcare providers to discuss patient wound care more efficiently. A distinctive aspect of NATROX IQ is the incorporation of AI, which offers precise measurements of wound depth and area, guaranteeing accurate assessments and careful treatment strategies.
Major companies operating in the artificial intelligence (AI) in wound care market are:
• Medtronic plc
• Stryker Corporation
• Smith & Nephew plc
• Convatec Group plc
• Mölnlycke Health Care AB
• Medela AG
• Derma Sciences Inc.
• Implicity Inc.
• Cecelia Health
• Swift Medical Inc.
• Spectral MD Inc.
• PolarityTE Inc.
• eKare Inc.
• KroniKare Pte Ltd.
• Perceptive Solutions Inc.
• Tissue Analytics Inc.
• WoundZoom Inc.
• Intellicure Inc.
• WoundMatrix Inc.
• WoundVision LLC
• The Wound Pros LLC
• MobileSmith Health
North America was the largest region in the artificial intelligence (AI) in wound care market in 2024. The regions covered in the artificial intelligence (AI) in wound care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.